Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

4.53

Margin Of Safety %

41

Put/Call OI Ratio

0.21

EPS Next Q Diff

0.02

EPS Last/This Y

-17.6

EPS This/Next Y

1.1

Price

271.27

Target Price

335

Analyst Recom

2

Performance Q

-11.85

Upside

126.4%

Beta

1.19

Ticker: BIO




17 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-01-23BIO296.350.070.00585
2026-01-26BIO299.270.060.09642
2026-01-27BIO297.640.060.00666
2026-01-28BIO299.730.073.00630
2026-01-29BIO294.650.091.00642
2026-01-30BIO293.090.09999.99644
2026-02-02BIO297.330.090.00645
2026-02-04BIO305.940.090.00685
2026-02-05BIO299.390.090.00687
2026-02-06BIO302.760.09999.99687
2026-02-09BIO294.830.0911.77687
2026-02-10BIO300.090.3250.00849
2026-02-11BIO293.860.400.00900
2026-02-12BIO292.060.390.19905
2026-02-13BIO256.470.321.802916
2026-02-18BIO270.040.210.002888
2026-02-19BIO271.50.210.002889
DateSymbolLatestP/C OIP/C VolTotal OI
17 items Current Page1 of 1




17 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-01-23BIO296.35-6.61111.29.95
2026-01-26BIO299.28-6.61122.09.95
2026-01-27BIO297.57-6.61117.79.95
2026-01-28BIO299.34-6.61121.09.95
2026-01-29BIO294.19-6.61113.59.95
2026-01-30BIO293.72-6.61117.39.95
2026-02-02BIO297.60-6.61122.79.95
2026-02-03BIO298.81-6.61124.39.95
2026-02-04BIO305.83-6.61128.59.95
2026-02-05BIO299.72-6.61115.79.95
2026-02-06BIO301.25-6.61124.39.95
2026-02-09BIO294.63-6.61114.09.95
2026-02-10BIO300.22-6.61126.19.95
2026-02-12BIO291.97-6.61118.09.95
2026-02-18BIO270.21-22.0-660.310.31
2026-02-19BIO271.50-22.0- 10.31
2026-02-20BIO271.27-22.0- 10.27
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
17 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-01-23BIO-0.015.424.78
2026-01-26BIO-0.018.934.78
2026-01-27BIO-0.018.934.78
2026-01-28BIO-0.018.934.38
2026-01-29BIO-0.018.934.38
2026-01-30BIO-0.018.934.38
2026-02-02BIO-0.017.824.38
2026-02-03BIO-0.017.824.38
2026-02-04BIO-0.017.824.38
2026-02-05BIO-0.017.824.38
2026-02-06BIO-0.017.824.38
2026-02-09BIO-0.014.454.38
2026-02-10BIO-0.014.454.38
2026-02-11BIO-0.014.454.53
2026-02-12BIO-0.014.454.53
2026-02-13BIO-0.014.454.53
2026-02-17BIO-0.013.074.53
2026-02-18BIO-0.013.074.53
2026-02-19BIO-0.013.074.53
2026-02-20BIO-0.013.074.53
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

2.51

Avg. EPS Est. Current Quarter

1.98

Avg. EPS Est. Next Quarter

2.53

Insider Transactions

-0.01

Institutional Transactions

3.07

Beta

1.19

Average Sales Estimate Current Quarter

585

Average Sales Estimate Next Quarter

658

Fair Value

383.28

Quality Score

93

Growth Score

41

Sentiment Score

41

Actual DrawDown %

67.4

Max Drawdown 5-Year %

-73.8

Target Price

335

P/E

9.72

Forward P/E

23.48

PEG

2.82

P/S

2.83

P/B

0.98

P/Free Cash Flow

19.54

EPS

27.92

Average EPS Est. Cur. Y​

10.27

EPS Next Y. (Est.)

11.37

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

29.42

Relative Volume

1.14

Return on Equity vs Sector %

-18.8

Return on Equity vs Industry %

-7.5

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.12

EBIT Estimation

Bio-Rad Laboratories, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees: 7450
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
stock quote shares BIO – Bio-Rad Laboratories, Inc. Stock Price stock today
news today BIO – Bio-Rad Laboratories, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch BIO – Bio-Rad Laboratories, Inc. yahoo finance google finance
stock history BIO – Bio-Rad Laboratories, Inc. invest stock market
stock prices BIO premarket after hours
ticker BIO fair value insiders trading